Attention:
Card image cap

Anti-Kickback Statute Master Class: Trends in Enforcement and Regulatory Guidance - What Should Be On Your AKS Radar?


Level: Advanced
Runtime: 92 minutes
Recorded Date: December 14, 2017
Click here to share this program
Printer-Friendly Version

Agenda

12:00 pm - 1:30 pm
  • Independent Sales Agents & Marketing
  • Recent Settlements and Enforcement Actions: The Federal Travel Act
  • Individual enforcement under AKS
  • Application of the AKS to Relationship with FHCP Beneficiaries
Runtime: 1 hour and 32 minutes
Recorded: December 14th, 2017
For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

This seminar will summarize new regulatory and legal developments in Anti-Kickback Statute enforcement and compliance.

Practitioners well versed in the basics of the Anti-Kickback Statute will learn strategic and practical considerations for evaluating regulatory and compliance risk in light of the government's ever-evolving enforcement climate.

This program was recorded on December 14th, 2017.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Karen S. Lovitch

Member
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.

Karen is the Practice Leader of the firm’s Health Law Practice. She counsels health care clients on regulatory, transactional, and operational issues, including Medicare coverage and reimbursement, the development and implementation of health care compliance programs, and licensure and certification matters. In addition, Karen advises clients on the legal, practical, and fraud and abuse implications of business arrangements and sales and marketing practices. Her experience includes matters related to the anti-kickback statute, the Stark law, state statutes prohibiting kickbacks and self-referrals, and the federal Physician Payments Sunshine Act.

Karen applies her compliance and regulatory experience in transactional as well as litigation contexts. In addition to counseling health care entities on regulatory matters arising in connection with mergers and acquisitions, she has successfully defended clients subject to state and federal surveys, Medicare and Medicaid overpayment and reimbursement appeals, and state licensure proceedings. Karen also represents clients subject to state and federal investigations alleging violation of the anti-kickback statute, the federal False Claims Act, and other state and federal laws.

Karen also specializes in the representation of laboratories and diagnostics companies. She regularly counsels on compliance with CLIA and state laboratory licensure laws, federal and state limitations on billing for diagnostic services, and legal restrictions on sales and marketing activities. Karen has served as regulatory counsel in a number of mergers and acquisitions involving laboratories and diagnostics companies and has represented numerous laboratories and diagnostics companies in state and federal government investigations.

Karen has written and lectured on a variety of issues confronting laboratories and others in the health care industry. She is the co-author of What Is…the Anti-Kickback Statute?, a book recently published by the American Bar Association.

Card image cap

Kate S. Stern

Senior Associate
King & Spalding LLP

Kate Stern is a senior associate in King & Spalding's Healthcare practice. Kate focuses on the representation of health systems, hospitals, physician organizations, academic medical centers, home health companies, retail pharmacy chains, large retailers with pharmacy operations, specialty pharmacies and management services organizations.

Kate has experience advising clients on a wide variety of healthcare regulatory matters, specifically including fraud and abuse laws such as the Stark law and the federal anti-kickback statute, Medicare and Medicaid regulation (including Medicare Advantage and audit and enforcement matters), EMTALA, HIPAA and various state laws and regulations that govern provider operations. She has experience with accountable care organizations, clinically integrated networks, shared savings and incentive payment compensation.

Kate also has experience creating and implementing compliance programs, implementing health information technology systems and electronic health records and drafting Medicare provider reimbursement appeals. In addition, Kate represents health industry clients in various transactional matters and government investigations.

Kate is an active member of the American Health Lawyers Association.

Card image cap

Joan B. Killgore

Shareholder
Polsinelli P.C.

Joan Killgore provides value to her clients by bringing specialized clinical and technical knowledge to the table, which enables her to quickly assess urgent matters and provide practical and creative recommendations. Her background includes experience as a pediatric hospital nurse and an adjunct professor for the Center for Health Care Studies at Saint Louis University School of Law, which has been ranked by U.S. News & World Report as the No. 1 health law program in the nation.

On a daily basis, Joan counsels clients on an array of health care regulatory, operational, and transactional matters. Joan has significant experience assisting clients with regulatory compliance matters, such as utilizing various federal agency disclosure procedures, when clients identify potential compliance issues.


Card image cap

Similar Courses

Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
76 minutes
But I’m Afraid of Needles: The Sale of Health Care Assets
This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
53 minutes
Conservatorship Criteria in Context: The Britney Spears Case
The Britney Spears conservatorship case has brought a lot of attention to the Conservatorships and Guardianship laws throughout the country. In this program, Dr. Brian Russell uses his expertise to provde some useful legal context to the case, provide lawyers with a better understanding of where the pitfalls are and how they can do right by their clients.

Dr. Brian Russell

$75

Add to Cart
Card image cap
86 minutes
COVID-19 Relief Funding & Reopening America: What's Really Happening in Congress
Please join a distinguished panel who will share their thoughts on how best to safely and gradually re-open business across America.

American Bankruptcy Institute

$115

Add to Cart
Previous Next